MedTrace Logo

Blood Glucose Variability and Insulin Action During Menstrual Cycle in Females With Type 1 Diabetes

NCT02693938 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 28

Last updated 2022-02-28

No results posted yet for this study

Summary

This research study is designed to look at differences in responsiveness to the subcutaneous injection of a standardized dose of rapid-acting insulin analog and blood glucose variability during different phases of the menstrual cycle in females with type 1 diabetes (T1D).

Conditions

Interventions

DEVICE

Follicular Euglycemic clamp

Follicular Euglycemic clamp during follicular phase

DEVICE

Luteal Euglycemic clamp

Luteal Euglycemic clamp during luteal phase

Sponsors & Collaborators

  • The Leona M. and Harry B. Helmsley Charitable Trust

    collaborator OTHER

  • Yale University

    lead OTHER

Principal Investigators

  • Eda Cengiz, MD, MHS · Yale University

Study Design

Allocation
NON_RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
12 Years
Max Age
35 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-11-13
Primary Completion
2020-02-07
Completion
2020-02-07

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02693938 on ClinicalTrials.gov